JPWO2021212097A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2021212097A5 JPWO2021212097A5 JP2022563191A JP2022563191A JPWO2021212097A5 JP WO2021212097 A5 JPWO2021212097 A5 JP WO2021212097A5 JP 2022563191 A JP2022563191 A JP 2022563191A JP 2022563191 A JP2022563191 A JP 2022563191A JP WO2021212097 A5 JPWO2021212097 A5 JP WO2021212097A5
- Authority
- JP
- Japan
- Prior art keywords
- fraction
- composition
- hyaluronic acid
- subject
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000203 mixture Substances 0.000 claims 17
- 229920002674 hyaluronan Polymers 0.000 claims 14
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims 13
- 229960003160 hyaluronic acid Drugs 0.000 claims 13
- 239000012736 aqueous medium Substances 0.000 claims 2
- 210000004207 dermis Anatomy 0.000 claims 2
- 239000011859 microparticle Substances 0.000 claims 2
- 229940079593 drug Drugs 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 210000002615 epidermis Anatomy 0.000 claims 1
- 238000002347 injection Methods 0.000 claims 1
- 239000007924 injection Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000002245 particle Substances 0.000 claims 1
- 230000004962 physiological condition Effects 0.000 claims 1
- 210000003491 skin Anatomy 0.000 claims 1
- 230000007928 solubilization Effects 0.000 claims 1
- 238000005063 solubilization Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 claims 1
- 238000007920 subcutaneous administration Methods 0.000 claims 1
- 239000000126 substance Substances 0.000 claims 1
- 230000008961 swelling Effects 0.000 claims 1
- 210000001179 synovial fluid Anatomy 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 125000003396 thiol group Chemical group [H]S* 0.000 claims 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 1
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US202063011996P | 2020-04-17 | 2020-04-17 | |
US63/011,996 | 2020-04-17 | ||
US202163136508P | 2021-01-12 | 2021-01-12 | |
US63/136,508 | 2021-01-12 | ||
PCT/US2021/027912 WO2021212097A1 (fr) | 2020-04-17 | 2021-04-19 | Compositions d'acide hyaluronique à libération contrôlée |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2023522079A JP2023522079A (ja) | 2023-05-26 |
JPWO2021212097A5 true JPWO2021212097A5 (fr) | 2024-04-30 |
Family
ID=78084900
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2022563191A Pending JP2023522079A (ja) | 2020-04-17 | 2021-04-19 | ヒアルロン酸組成物の制御放出 |
Country Status (4)
Country | Link |
---|---|
US (1) | US20230172968A1 (fr) |
EP (1) | EP4135772A4 (fr) |
JP (1) | JP2023522079A (fr) |
WO (1) | WO2021212097A1 (fr) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP4415771A1 (fr) * | 2021-10-15 | 2024-08-21 | Prohibix LLC | Précipités d'acide hyaluronique réticulé |
WO2023064624A1 (fr) * | 2021-10-15 | 2023-04-20 | Prohibix Llc | Compositions d'hydrogel gonflantes et stimulant le collagène |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5166331A (en) * | 1983-10-10 | 1992-11-24 | Fidia, S.P.A. | Hyaluronics acid fractions, methods for the preparation thereof, and pharmaceutical compositions containing same |
US20060153893A1 (en) * | 2002-04-08 | 2006-07-13 | Denki Kagaku Kogyo Kabushiki Kaisha | Therapeutic composition for bone infectious disease |
US8821928B2 (en) * | 2007-06-04 | 2014-09-02 | Egalet Ltd. | Controlled release pharmaceutical compositions for prolonged effect |
US8357795B2 (en) * | 2008-08-04 | 2013-01-22 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
US11090387B2 (en) * | 2008-12-22 | 2021-08-17 | The Trustees Of The University Of Pennsylvania | Hydrolytically degradable polysaccharide hydrogels |
EP2459239A1 (fr) * | 2009-07-30 | 2012-06-06 | Carbylan Biosurgery, Inc. | Compositions de polymère d'acide hyaluronique et procédés associés |
FR3006689A1 (fr) * | 2013-06-11 | 2014-12-12 | Benedicte Vincente Tauzin | Procede de reticulation de l'acide hyaluronique; procede de preparation d'un hydrogel injectable; hydrogel obtenu; utilisation de l'hydroget obtenu |
WO2015005345A1 (fr) * | 2013-07-08 | 2015-01-15 | 電気化学工業株式会社 | Particules à noyau-coquille de gel d'acide hyaluronique réticulé, leur procédé de production et matériau médical |
KR101459070B1 (ko) * | 2013-12-09 | 2014-11-17 | (주) 뉴메딕 | 지속성을 갖는 히알루론산 겔 조성물 |
WO2017114867A1 (fr) * | 2015-12-29 | 2017-07-06 | Galderma S.A. | Réticulateur de glucides |
WO2017136427A1 (fr) * | 2016-02-02 | 2017-08-10 | The Regents Of The University Of California | Hydrogel permettant la sélection de cellule progénitrice neurologique endogène |
-
2021
- 2021-04-19 US US17/919,410 patent/US20230172968A1/en active Pending
- 2021-04-19 EP EP21789588.7A patent/EP4135772A4/fr active Pending
- 2021-04-19 JP JP2022563191A patent/JP2023522079A/ja active Pending
- 2021-04-19 WO PCT/US2021/027912 patent/WO2021212097A1/fr unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN109528695B (zh) | 一种治疗类风湿性关节炎的微针透皮给药贴片及其制备方法 | |
JP3094074B2 (ja) | 多糖ゲル組成物 | |
KR101224939B1 (ko) | 활성 성분의 흡수 속도가 개선된 마이크로니들 | |
KR101400545B1 (ko) | 마이크로니들 디바이스 및 그의 제조 방법 | |
JP2003533468A (ja) | タンパク質マトリクス物質、製造並びにその製造及び使用 | |
TWI675666B (zh) | 溶解特性優秀的透明質酸微結構體 | |
C Patel et al. | Recent patents on stimuli responsive hydrogel drug delivery system | |
JP2007532173A (ja) | 軟組織増大用の粒子 | |
JP7345792B2 (ja) | マイクロニードルパッチを用いたヒアルロン酸フィラー | |
JP2007537249A (ja) | 荷電ポリマーを含むゲル組成物 | |
JP2010535188A (ja) | 関節疾患若しくは関節痛の治療用又は審美的な目的若しくは他の目的のための皮膚の治療用の方法及び化合物並びに化合物の調製方法 | |
CN105209075A (zh) | 生物相容性原位水凝胶 | |
CN109621181A (zh) | 一种光热响应性复合微针及其制备方法 | |
JP2694372B2 (ja) | 微小移植物質 | |
KR20190118155A (ko) | 주사용 필러 및 콜라겐 성장을 위한 스캐폴드로 유용한 실리콘 수중유형 조성물 | |
JP2014510590A (ja) | フィラー製品および少なくとも1つの生体吸収性および生分解性シリカベースの材料を含む組成物 | |
US20120035531A1 (en) | On-demand and reversible drug release by external cue | |
KR20140133724A (ko) | 저분자 메틸셀룰로오스 기반의 비경구 약물 전달 시스템 | |
CN110327488A (zh) | 一种注射填充微球制剂及其制备方法 | |
JPWO2021212097A5 (fr) | ||
CN110538166B (zh) | 聚乙烯醇缓释膜、聚乙烯醇缓释微针及其制备方法 | |
KR101898816B1 (ko) | 저분자 메틸셀룰로오스 기반의 비경구 약물 전달 시스템 | |
KR102460006B1 (ko) | 폴리뉴클레오타이드 및 히알루론산 포함하는 피부 필러 조성물의 동결건조 제조방법 및 이에 따라 제조된 폴리뉴클레오타이드 및 히알루론산 포함하는 피부 필러 조성물 | |
JP2022500177A (ja) | 微細構造体基盤薬物注入装置およびその製造方法 | |
CN114948852B (zh) | 一种用于脑部疾病诊断和治疗的微针系统及其制备方法 |